Literature DB >> 24635393

Mortality in patients presenting with fever of unknown origin.

S Vanderschueren, T Eyckmans, P De Munter, D Knockaert.   

Abstract

BACKGROUND: Few data exist on the contemporary prognosis of patients presenting with fever of unknown origin (FUO).
METHODS: The data of 436 adult immunocompetent patients presenting with FUO between 2000 and 2010 and followed for at least 6 months were analyzed, with a focus on FUO-related deaths. The following variables were assessed in survivors and non-survivors: age, underlying diagnosis, and, in a nested case-control design, fever periodicity, selected laboratory parameters (including peripheral blood counts, enzymes, and inflammatory markers) and organomegaly.
RESULTS: Thirty FUO-related deaths occurred (6·9%). Malignancy accounted for 11% of fevers but for 60% of deaths. Especially non-Hodgkin lymphoma carried a disproportionally high death toll. In the non-malignant categories, fatality rates were below 6%. All patients discharged without diagnosis in spite of ample investigations (n = 164) survived. Besides malignancy, age, continuous (as opposed to episodic) fever, anaemia, leucopenia, LDH levels, and hepatomegaly were associated with mortality.
CONCLUSIONS: Fatality rates of FUO have continuously declined over the past decades. Malignancy, including lymphoma, remains a cardinal cause of death. Patients with FUO discharged without diagnosis survive.

Entities:  

Keywords:  Fever of unknown origin,; Fever,; Mortality,; Outcome

Mesh:

Year:  2014        PMID: 24635393     DOI: 10.1179/0001551213Z.0000000005

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  9 in total

1.  Fever of unknown origin, giant cell arteritis, and aortic dissection.

Authors:  K Hofheinz; S Bertz; J Wacker; G Schett; B Manger
Journal:  Z Rheumatol       Date:  2017-02       Impact factor: 1.372

Review 2.  Pyrexia of unknown origin.

Authors:  Cristina Fernandez; Nick J Beeching
Journal:  Clin Med (Lond)       Date:  2018-03       Impact factor: 2.659

3.  Screening for dental focal infections in febrile patients with hematologic malignancies who received chemotherapy: a retrospective cohort study.

Authors:  Yasuyuki Shimada; Yohei Kawasaki; Ryo Nasu; Fumihiko Nakamura; Yutaka Maruoka
Journal:  Glob Health Med       Date:  2020-08-31

Review 4.  Optimal use of the FDG-PET/CT in the diagnostic process of fever of unknown origin (FUO): a comprehensive review.

Authors:  Ryogo Minamimoto
Journal:  Jpn J Radiol       Date:  2022-07-04       Impact factor: 2.374

5.  Characteristics of acute febrile illness and determinants of illness recovery among adults presenting to Singapore primary care clinics.

Authors:  Zaw Myo Tun; Mahesh Moorthy; Martin Linster; Yvonne Cf Su; Richard James Coker; Eng Eong Ooi; Jenny Guek-Hong Low; Gavin J D Smith; Clarence C Tam
Journal:  BMC Infect Dis       Date:  2016-10-28       Impact factor: 3.090

6.  Comparison of classical diagnostic criteria and Chinese revised diagnostic criteria for fever of unknown origin in Chinese patients.

Authors:  Jia-Jun Li; Wen-Xiang Huang; Zheng-Yu Shi; Qiu Sun; Xiao-Juan Xin; Jin-Qiu Zhao; Zhen Yin
Journal:  Ther Clin Risk Manag       Date:  2016-10-12       Impact factor: 2.423

7.  Long-term prognosis, treatment, and outcome of patients with fever of unknown origin in whom no diagnosis was made despite extensive investigation: A questionnaire based study.

Authors:  Catharina M Mulders-Manders; Celeste Engwerda; Anna Simon; Jos W M van der Meer; Chantal P Bleeker-Rovers
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

8.  Safety and efficacy of outpatient follow-up for referred patients with undiagnosed fever: A retrospective cohort study.

Authors:  Yukinori Harada; Mikako Masuda; Takanobu Hirosawa; Hiroshi Takase; Kohei Morinaga; Michihiro Nin; Taro Shimizu
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889

Review 9.  Fever and Fever of Unknown Origin: Review, Recent Advances, and Lingering Dogma.

Authors:  William F Wright; Paul G Auwaerter
Journal:  Open Forum Infect Dis       Date:  2020-05-02       Impact factor: 3.835

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.